Work-related experiences and unmet needs of patients with a malignant glioma and relevant professionals: the BrainWork study

Author:

Zegers Amber Daniëlle,Coenen Pieter,Heeren Amy,Takke Nadia,Ardon Hilko,Compter Annette,Dona Desiree,Kouwenhoven Mathilde,Schagen Sanne B.,de Vos Filip,Duijts Saskia F. A.

Abstract

Abstract Purpose Many patients with a malignant (i.e., grade II-IV) glioma are of working age, yet they are rarely included in “cancer and work” studies. Here, we explored (1) the work-related experiences and unmet needs of patients with a malignant glioma and (2) the experiences and needs of relevant healthcare and occupational (health) professionals (“professionals”) in providing work-related support to this patient group. Methods Individual semi-structured interviews were held with patients with a malignant glioma who were of working age and had an employment contract at diagnosis, and relevant professionals. Interviews were transcribed verbatim and analysed thematically. Results Patients (n = 22) were on average 46 ± 13 years of age (64% male) and diagnosed with a grade II (n = 12), III (n = 4), or IV glioma (n = 6). Professionals (n = 16) had on average 15 ± 9 years of relevant work experience with the patient group. Four themes emerged from the data: (1) having a malignant glioma: experienced consequences on work ability, (2) communicating about the consequences of a malignant glioma at work, (3) distilling the right approach: generic or tailored work-related support, and (4) accessibility of work-related support. Conclusions Glioma-specific consequences on patients’ work ability necessitate better communication between, and tailored guidance for, patients, relevant professionals, and the workplace. Suggestions for improvement, e.g., the periodic use of comprehensive neuropsychological assessments, are provided in the article. Implications for cancer survivors Patients with a malignant glioma would benefit from tailored and proactive outreach about work-related issues bv relevant professionals.

Publisher

Springer Science and Business Media LLC

Subject

Oncology (nursing),Oncology

Reference52 articles.

1. Goodenberger ML, Jenkins RB. Genetics of adult glioma. Cancer Genet. 2012;205(12):613–21.

2. Netherlands Comprehensive Cancer Organisation. Overleving hersentumoren [Prognosis of brain tumors]. n.d. https://iknl.nl/kankersoorten/hersentumoren/registratie/overleving. Accessed 24 April 2023.

3. Netherlands Comprehensive Cancer Organisation. Incidentie hersentumoren (Incidence of brain tumours). n.d. https://iknl.nl/kankersoorten/hersentumoren/registratie/incidentie. Accessed 24 April 2023.

4. Netherlands Comprehensive Cancer Organisation. Hersentumoren [Brain tumors]. n.d. https://iknl.nl/kankersoorten/hersentumoren. Accessed 24 April 2023.

5. Ho VK, Reijneveld JC, Enting RH, Bienfait HP, Robe P, Baumert BG, et al. Changing incidence and improved survival of gliomas. Eur J Cancer. 2014;50(13):2309–18.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Patient-reported outcomes in neuro-oncology;Current Opinion in Oncology;2024-07-05

2. High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma;Frontiers in Oncology;2024-03-20

3. A Review of The Applications of Deep Learning In the Treatment of Glioma;Proceedings of the 2023 4th International Symposium on Artificial Intelligence for Medicine Science;2023-10-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3